share_log

Assure | DEFA14A: Others

Assure | DEFA14A: Others

Assure | DEFA14A:其他
美股sec公告 ·  04/26 06:13
Moomoo AI 已提取核心信息
Assure Holdings Corp. has announced a Special Meeting of Shareholders scheduled for April 30, 2024, to vote on a proposal to increase the authorized shares of common stock. This move is part of the company's efforts to complete a merger with Danam Health, Inc., which is contingent upon Assure maintaining its Nasdaq listing and reducing its total liabilities to no more than $500,000. The merger is expected to close by July 22, 2024, but there is no guarantee. Management has outlined a series of tasks to prepare for the merger, including negotiations and settlements of debts in exchange for common shares. The company believes it has sufficient cash to fund operations until the deal closes, but failure to secure shareholder approval for the increase...Show More
Assure Holdings Corp. has announced a Special Meeting of Shareholders scheduled for April 30, 2024, to vote on a proposal to increase the authorized shares of common stock. This move is part of the company's efforts to complete a merger with Danam Health, Inc., which is contingent upon Assure maintaining its Nasdaq listing and reducing its total liabilities to no more than $500,000. The merger is expected to close by July 22, 2024, but there is no guarantee. Management has outlined a series of tasks to prepare for the merger, including negotiations and settlements of debts in exchange for common shares. The company believes it has sufficient cash to fund operations until the deal closes, but failure to secure shareholder approval for the increase in authorized shares could lead to the consumption of its cash reserves and potentially result in winding down operations or filing for bankruptcy. Additionally, without the approval, Assure would be unable to consider any strategic investments due to a lack of available shares to sell. The Board of Directors strongly supports the proposal to increase the authorized shares to 250 million, emphasizing that the approval does not mean the shares will be issued immediately but will be available if needed. Shareholders are urged to vote in favor of the proposal to ensure the company's ability to maximize value and maintain operations.
Assure Holdings Corp. 宣布了定于2024年4月30日举行的股东特别会议,将对增加普通股授权股份的提案进行表决。此举是该公司完成与Danam Health, Inc. 合并的努力的一部分,前提是Assure维持在纳斯达克的上市并将其总负债减少至不超过50万美元。合并预计将于2024年7月22日完成,但无法保证。管理层概述了为合并做准备的一系列任务,包括谈判和清偿债务以换取普通股。该公司认为,在交易完成之前,它有足够的现金为运营提供资金,但未能获得股东批准增加法定股份,可能会导致其现金储备消耗,并可能导致业务结束或申请破产。此外,未经批准,由于缺乏可供出售的股票,Assure将无法考虑任何战略投资。董事会坚决支持将授权股份增加到2.5亿股的提议,强调该批准并不意味着股票将立即发行,而是在需要时可以发行。敦促股东对该提案投赞成票,以确保公司实现价值最大化和维持运营的能力。
Assure Holdings Corp. 宣布了定于2024年4月30日举行的股东特别会议,将对增加普通股授权股份的提案进行表决。此举是该公司完成与Danam Health, Inc. 合并的努力的一部分,前提是Assure维持在纳斯达克的上市并将其总负债减少至不超过50万美元。合并预计将于2024年7月22日完成,但无法保证。管理层概述了为合并做准备的一系列任务,包括谈判和清偿债务以换取普通股。该公司认为,在交易完成之前,它有足够的现金为运营提供资金,但未能获得股东批准增加法定股份,可能会导致其现金储备消耗,并可能导致业务结束或申请破产。此外,未经批准,由于缺乏可供出售的股票,Assure将无法考虑任何战略投资。董事会坚决支持将授权股份增加到2.5亿股的提议,强调该批准并不意味着股票将立即发行,而是在需要时可以发行。敦促股东对该提案投赞成票,以确保公司实现价值最大化和维持运营的能力。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息